PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 87 filers reported holding PAIN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $31,000 | +55.0% | 34,537 | 0.0% | 0.02% | +40.0% |
Q4 2016 | $20,000 | -47.4% | 34,537 | -8.2% | 0.02% | -48.3% |
Q3 2016 | $38,000 | -53.7% | 37,637 | 0.0% | 0.03% | -54.7% |
Q2 2016 | $82,000 | -2.4% | 37,637 | 0.0% | 0.06% | -4.5% |
Q1 2016 | $84,000 | +47.4% | 37,637 | +15.3% | 0.07% | +31.4% |
Q4 2015 | $57,000 | -5.0% | 32,637 | 0.0% | 0.05% | -7.3% |
Q3 2015 | $60,000 | +7.1% | 32,637 | 0.0% | 0.06% | +7.8% |
Q2 2015 | $56,000 | -9.7% | 32,637 | 0.0% | 0.05% | +2.0% |
Q1 2015 | $62,000 | -7.5% | 32,637 | -1.8% | 0.05% | -3.8% |
Q4 2014 | $67,000 | -84.4% | 33,237 | -69.8% | 0.05% | -85.5% |
Q3 2014 | $430,000 | -32.5% | 109,937 | -0.8% | 0.36% | -32.3% |
Q2 2014 | $637,000 | +4.4% | 110,837 | 0.0% | 0.53% | +7.3% |
Q1 2014 | $610,000 | -9.4% | 110,837 | -20.0% | 0.49% | -13.1% |
Q4 2013 | $673,000 | +320.6% | 138,520 | +135.4% | 0.57% | +258.9% |
Q3 2013 | $160,000 | +23.1% | 58,837 | 0.0% | 0.16% | +23.4% |
Q2 2013 | $130,000 | – | 58,837 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |